berotek has been researched along with Adverse Drug Event in 5 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity Currently tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit." | 1.40 | [Tocolysis in preterm labour--current recommendations]. ( Bomba-Opoń, DA; Wielgoś, M, 2014) |
| " None have done this during a time when prescribers have been just made aware of potential serious adverse events that might be caused by a commonly prescribed medication." | 1.29 | The effect of a warning about putative adverse events on drug prescribing in general practice. ( Barham, PM; Thomson, AN, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tzvetkov, MV | 1 |
| Matthaei, J | 1 |
| Pojar, S | 1 |
| Faltraco, F | 1 |
| Vogler, S | 1 |
| Prukop, T | 1 |
| Seitz, T | 1 |
| Brockmöller, J | 1 |
| Wielgoś, M | 1 |
| Bomba-Opoń, DA | 1 |
| Pearce, N | 1 |
| Thomson, AN | 1 |
| Barham, PM | 1 |
| Windorfer, A | 1 |
| Stünkel, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Genetic Polymorphisms in the Organic Cation Transporter OCT1 on Cellular Uptake and Metabolism of Antidepressants and Other Organic Cationic Drugs[NCT02054299] | Phase 1 | 48 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for berotek and Adverse Drug Event
| Article | Year |
|---|---|
Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency.
Topics: Alleles; Biological Transport; Blood Glucose; Cardiovascular System; Drug-Related Side Effects and A | 2018 |
4 other studies available for berotek and Adverse Drug Event
| Article | Year |
|---|---|
[Tocolysis in preterm labour--current recommendations].
Topics: Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Relat | 2014 |
The use of beta agonists and the risk of death and near death from asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Asthma; Bias; Case-Control Studies; Child; Child, Presc | 2009 |
The effect of a warning about putative adverse events on drug prescribing in general practice.
Topics: Attitude of Health Personnel; Drug Information Services; Drug Prescriptions; Drug-Related Side Effec | 1993 |
[Significance of pharmacogenic liver reactions for metabolism of endogenous and exogenous substances].
Topics: Carbamazepine; Diazepam; Drug-Related Side Effects and Adverse Reactions; Female; Fenoterol; Humans; | 1979 |